SIGN-IN

Publication: Parameterization of the proline analogue Aze (azetidine-2-carboxylic acid) for molecular dynamics simulations and evaluation of its effect on homo-pentapeptide conformations

All || By Area || By Year

Title Parameterization of the proline analogue Aze (azetidine-2-carboxylic acid) for molecular dynamics simulations and evaluation of its effect on homo-pentapeptide conformations
Authors/Editors* K. Bessonov, K.A. Vassall, G. Harauz
Where published* Journal of Molecular Graphics and Modelling
How published* Journal
Year* 2013
Volume 39C
Number 2
Pages 118
Publisher 125
Keywords Aze (azetidine-2-carboxylic acid); poly-proline II; cis-trans isomerization; molecular dynamics; GROMACS: myelin basic protein; intrinsically disordered protein; multiple sclerosis;
Link doi: 10.1016/j.jmgm.2012.11.006
Abstract
We have parameterized and evaluated the proline homologue Aze (azetidine-2-carboxylic acid) for the gromos56a3 force-field for use in molecular dynamics simulations using GROMACS. Using bi-phasic cyclohexane/water simulation systems and homo-pentapeptides, we measured the Aze solute interaction potential energies, ability to hydrogen bond with water, and overall compaction, for comparison to Pro, Gly, and Lys. Compared to Pro, Aze has a slightly higher H-bonding potential, and stronger electrostatic but weaker non-electrostatic interactions with water. The 20-ns simulations revealed the preferential positioning of Aze and Pro at the interface of the water and cyclohexane layers, with Aze spending more time in the aqueous layer. We also demonstrated through simulations of the homo-pentapeptides that Aze has a greater propensity than Pro to undergo trans  cis peptide bond isomerization, which results in a severe 180° bend in the polypeptide chain. The results provide evidence for the hypothesis that the misincorporation of Aze within proline-rich regions of proteins could disrupt the formation of poly-proline type II structures and compromise events such as recognition and binding by SH3-domains.
Go to Myelin And Multiple Sclerosis
Back to page 1 of list